GlassScriptPhysician profile
Brandon Liang
NPI 1235544453
$1,426.77
in general payments reported to CMS, 2019-2025
10 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.58 · 2022: $372 · 2023: $597 · 2024: $177 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $579.97 | 2022-2024 | Alto Abdominal Stent Graft System |
| Silk Road Medical, INC. | $196.08 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Bolton Medical INC | $146.89 | 2023 | Treo Abdominal Stent-Graft System |
| Surmodics, INC. | $126.36 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Boston Scientific Corporation | $123.88 | 2025 | General - Vascular Intervention |
| Osteomed LLC | $72.87 | 2021-2022 | |
| Penumbra, INC. | $59.78 | 2025 | Ruby Coil |
| Angiodynamics, INC. | $56.64 | 2024 | Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $38.63 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Reflow Medical INC | $25.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.